Forest Laboratories
Latest Forest Laboratories News
-
Icahn Nominates 4 Candidates to Forest Labs Board
Forest Laboratories Inc. said Monday a fund affiliated with billionaire investor Carl Icahn plans to nominate four directors to Forest's board
-
Corporate Buyout Deals Nudge Indexes Higher
it doubts the country will be able to sell bonds to finance its budgets in 2012. Among U.S. corporations, Forest Laboratories Inc. rose nearly 2 percent after the drugmaker said a fund affiliated with billionaire investor Carl Icahn plans
-
Wendy's/Arby's, Timberland, Chico's Are Big Movers
owner of the Wrangler, Nautica and The North Face brands, is buying the bootmaker for more than $2.2 billion. Forest Laboratories Inc., up 62 cents at $38.57 The drugmaker said a fund affiliated with billionaire investor Carl Icahn plans
-
In Shift, Feds Target Top Execs for Health Fraud
case is playing out with an 83-year-old drug company chief executive, Howard Solomon of New York City-based Forest Laboratories . Forest makes antidepressants, blood pressure drugs and other medications. Last month, the inspector general
-
In Shift, Feds Target Top Execs for Health Fraud
case is playing out with an 83-year-old drug company chief executive, Howard Solomon of New York City-based Forest Laboratories . Forest makes antidepressants, blood pressure drugs and other medications. Last month, the inspector general
-
Big Corporate Profits, Small Tax BillHow GE, Boeing and Others Make Billions But Pay Relatively Little or No Tax: It's All Legal
News
-
Celexa May Not Help Kids With Autism
movements, the study found. In a statement, Forest Laboratories , the maker of Celexa, said that it "was not Washington, Seattle; June 1, 2009, statement, Forest Laboratories ; June 2009, Archives of General Psychiatry
-
Lexapro Approved for Adolescent Depression
FRIDAY, March 20 (HealthDay News) -- The Forest Laboratories antidepressant Lexapro (escitalopram oxalate) has been approved to treat major depressive disorder (MDD) in people aged 12
-
Johnson & Johnson Q4 profit rises 14%, but revenue drops
international and domestic," Leerink Swann analyst Rick Wise said in a research report. Another U.S. drugmaker, Forest Laboratories frx , posted a 38% decline in quarterly profit Tuesday on charges for licensing new medicines, but shares rose
-
Antidepressant May Help Compulsive Shoppers
patients, who took the drug citalopram, made by Forest Laboratories Inc. under the name Celexa, for three months names including Celexa, Cipramil and Seropram. Forest Laboratories funded the study.
